Source: Health Products Regulatory Authority (IE) Revision Year: 2023 Publisher: Tillotts Pharma GmbH, Warmbacher Strasse 80, DE- 79618 Rheinfelden, Germany
Asacolon 800mg Gastro-resistant Tablets.
| Pharmaceutical Form |
|---|
|
Gastro-resistant tablet. The tablets are reddish to brownish and oblong-shaped. |
Each gastro resistant tablet contains: 800mg mesalazine.
Excipient with known effect: 152.8mg lactose, see section 4.4.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mesalazine |
Mesalazine is an aminosalicylate. The mechanism of action of mesalazine is not fully understood, but appears to have a topical anti-inflammatory effect on the colonic epithelial cells. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase and lipoxygenase pathways, is increased in patients with chronic inflammatory bowel disease, and it is possible that mesalazine diminishes inflammation by blocking cyclooxygenase and inhibiting prostaglandin production in the colon. |
| List of Excipients |
|---|
|
Lactose monohydrate Film Coating: Methacrylic acid-methyl methacrylate copolymer (1:2) |
Blister strips of aluminium foil and PVC, and outer cardboard carton containing 90 tablets per pack.
Tillotts Pharma GmbH, Warmbacher Strasse 80, DE- 79618 Rheinfelden, Germany
PA2018/001/002
Date of first authorisation: 07 February 2003
Date of last renewal: 07 February 2008
| Drug | Countries | |
|---|---|---|
| ASACOLON | Ireland, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
